Watkins R W, Vemulapalli S, Baum T
Pharmacol Res Commun. 1984 May;16(5):447-50. doi: 10.1016/s0031-6989(84)80012-0.
We sought to determine if the hypotension and bradycardia caused by disodium cromoglycate (DSC) and veratrine sulfate were due to an action upon a common receptor. Tolerance rapidly developed to the hypotensive and bradycardic action of 10 micrograms/kg iv DSC in anesthetized dogs. Veratrine sulfate 30 micrograms/kg iv given after tolerance had developed to DSC gave falls in blood pressure and heart rate identical to those produced by the alkaloid before DSC tolerance had set in. Thus, no cross-tolerance between DSC and veratrine was observed. This result excludes the possibility of a common site of action for DSC and veratrine.
我们试图确定色甘酸钠(DSC)和硫酸藜芦碱引起的低血压和心动过缓是否是由于作用于共同受体。在麻醉犬中,对静脉注射10微克/千克DSC的降压和减慢心率作用迅速产生耐受。在对DSC产生耐受后,静脉注射30微克/千克硫酸藜芦碱,其血压下降和心率减慢程度与在DSC耐受出现之前该生物碱所产生的作用相同。因此,未观察到DSC与硫酸藜芦碱之间的交叉耐受。这一结果排除了DSC和硫酸藜芦碱存在共同作用部位的可能性。